title: [Role of intracellular zinc in programmed cell death].
abstract: Apoptosis is a type of cell death involved in several biological events during tissue development, remodelling or involution. It could be induced by several extracellular or intracellular stimuli with an important role for metals like zinc or calcium. Cellular zinc is described as an inhibitor of apoptosis, while its depletion induces death in many cell lines. Using different chemical tools like specific zinc-chelators or ionophores, it is possible to study and understand the mechanisms of programmed cell death induction. The decrease in intracellular zinc concentration induces a characteristic apoptosis with apoptotic bodies formation and nuclear DNA condensation and fragmentation. This zinc depletion activates the caspases-3, -8 and -9, responsible for the proteolysis of several target proteins like poly(ADP-ribose) polymerase or transcription factors. Zinc addition in cell culture medium prevents the apparition of morphological and biochemical signs induced by intracellular zinc chelation, but also by other apoptosis inducers like etoposide or tumour necrosis factor alpha (TNF alpha). However, excess of zinc can also be cytotoxic. The balance between life and cell death is maintained by several zinc channels, controlling the intracellular zinc movements and the free amount of the metal.
authors: Laboratoire de biologie du stress oxydant LRC 8M CEA associé INRA, université J. Fourier, Domaine de la Merci, 38700 La Tronche, France. Michel.Seve@ujf-grenoble.fr
authors: M
authors: M
authors: Seve
authors: F
authors: F
authors: Chimienti
authors: A
authors: A
authors: Favier
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D002352:Carrier Proteins / Q000378:metabolism; D053148:Caspase 3; D053181:Caspase 8; D053453:Caspase 9; D061945:Caspase Inhibitors; D020169:Caspases / Q000502:physiology; D002384:Catalysis; D027682:Cation Transport Proteins; D002467:Cell Nucleus / Q000378:metabolism; D002478:Cells, Cultured / Q000187:drug effects; D002614:Chelating Agents / Q000494:pharmacology; D003470:Culture Media; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D053938:DNA Fragmentation; D004789:Enzyme Activation; D005029:Ethylenediamines / Q000494:pharmacology; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D007424:Intracellular Fluid / Q000378:metabolism; D017136:Ion Transport; D008565:Membrane Proteins / Q000378:metabolism; D026901:Membrane Transport Proteins; D008667:Metalloproteins / Q000737:chemistry / Q000502:physiology; D008668:Metallothionein / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D015032:Zinc / Q000494:pharmacology / Q000502:physiology*
chemical_list: D002352:Carrier Proteins; D061945:Caspase Inhibitors; D027682:Cation Transport Proteins; D002614:Chelating Agents; D003470:Culture Media; D015853:Cysteine Proteinase Inhibitors; D005029:Ethylenediamines; D008565:Membrane Proteins; D026901:Membrane Transport Proteins; D008667:Metalloproteins; C486299:SLC30A2 protein, human; C102806:SLC30A3 protein, human; C491597:SLC30A4 protein, human; C485803:Slc30a1 protein, mouse; C491177:Slc30a3 protein, mouse; C491596:Slc30a4 protein, rat; D014409:Tumor Necrosis Factor-alpha; D005047:Etoposide; D008668:Metallothionein; C505407:CASP3 protein, human; C505530:CASP8 protein, human; C506433:CASP9 protein, human; C505409:Casp3 protein, mouse; C505410:Casp3 protein, rat; C505526:Casp8 protein, mouse; C505528:Casp8 protein, rat; C506434:Casp9 protein, mouse; C506435:Casp9 protein, rat; D053148:Caspase 3; D053181:Caspase 8; D053453:Caspase 9; D020169:Caspases; D015032:Zinc; C044387:N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine